Chronification and reversibility of migraine.
Phase of Trial: Phase IV
Latest Information Update: 04 Nov 2016
At a glance
- Drugs Botulinum toxin A (Primary)
- Indications Migraine; Secondary headache disorders; Tension type headache
- Focus Therapeutic Use
- Acronyms CHARM
- 13 Jul 2016 Status changed from recruiting to completed.
- 21 Jul 2012 New source identified and integrated (European Clinical Trials Database; EudraCT2011-005124-18).
- 21 Jul 2012 Actual initiation date 12 Jul 2012 added as reported by EudraCT.